Area Development
Archives
Current Issue
State Resources
  
Topics
Asset Management
Business Globalization
Economics/ Government Policy
Energy/Sustainable Development
International Location Reports
Labor/Education/HR
Logistics/Infrastructure
News Items
Site Selection/Facility Planning
Taxes/Incentives
Viewpoint
Exclusive Content
100 Leading Locations
2011 Gold & Silver Shovel Awards
Annual Corporate & Consultants Survey Results
Contributed Content
Economic Developers Directory
Front Line
Studies/Research/Papers
Top Site Selection Factors
Top States for Doing Business
Ask Area Development
Industry Reports
Aerospace
Automotive
Biotech
Food Processing
High Tech/Nano/Electronics
Medical/Pharmaceutical
Other Industries
Plastics
Inward Investment Guides
Location USA
Related Sites
FastFacility
FacilityLocations
Location Canada
Consultants Site Guide
FastGIS
Services
Consultants Forum
Newsletter  |  RSS RSS
Subscribe to Area Development Magazine
Advertise
About Us
Contact
Newsletters
Email Address*
Primary Industry
Area Development Homepage >> News Items >>
Sanofi-Aventis Invests $65M in Cambridge, Massachusetts Growth
Area Development Online News Desk (07/08/2010)
Sanofi-Aventis, one of the world’s biggest pharmaceutical companies, is investing $65 million to expand its Cambridge, Massachusetts facility, and will hire 300 additional employees, the Boston Globe reports. The company, which is located in Paris, France, will set up its cancer division’s new joint headquarters.

“We believe that Cambridge is really the heart of oncology today,’’ Hanspeter Spek, president of Sanofi-Aventis global operations, said in a company conference call this year. “We intend to benefit from this environment as a neighbor.’’

Massachusetts is banking on the pharmaceutical industry to buoy the state’s economy. Two years ago Governor Deval Patrick began a $1 billion, 10-year plan to offer tax incentives to life sciences companies. Last year, 26 companies received a total of $24.5 million.

Sanofi-Aventis has applied for $2.45 million in state tax credits from the Life Sciences Center, and will ask for another $6.5 million over the next four years.

Several other foreign pharmaceutical companies have facilities around Boston, such as Novartis, Merck, GlaxoSmithKline, and AstraZeneca.
 
X
Save/Share Article
More
 Email
Print
News Items
 
Around The Web
 
Studies/Research
News Items
 
Around The Web
 
Studies/Research
NY-Based Financial Firm Investing $4 Million to Relocate HQ to KY & Create 95 Jobs
02/07/2012
Holley Performance Products to Create 136 Jobs as Part of KY Expansion
02/07/2012
Advance Auto Parts to Invest $8 million in VA Customer Center & Create 75 Jobs
02/07/2012
Honeywell to Invest $27.5 Million at Its Virginia Facility & Create 50 Jobs
02/06/2012
Food Processor Expects to Hire Up to 50 Workers by 2014 for NC Processing Plant
02/06/2012
BNSF Railway: Plan to Invest $3.9 Billion in Its 2012 Capital Program
02/03/2012
Connecture to Create Over 100 Technology Jobs Near Milwaukee, Wisconsin
02/03/2012
AddThis Feed
<< More Recent Next >>
Government Competitiveness Report: Manufacturing Is America’s Biggest Source for Innovation
U.S. Department of Commerce
JLL's Global Life Science Cluster Report Examines Emerging & Established Clusters
Jones Lang LaSalle
Grubb & Ellis 2012 Forecast: Commercial Real Estate Sales Could Rise 25%
Grubb & Ellis
Washington, D.C., Tops 2011 List of "Best Cities for Business"
Wall Street Journal MarketWatch
New Global Trends Report Indicates Foreign Direct Investment Is Ramping Up Worldwide
IBM Global Business Services, IBM Institute for Business Value
Manufacturing Industry Needs to Fill 600,000 Skilled Positions
Deloitte
The Manufacturing Institute
2011 Top States For Doing Business Survey Results
Area Development Magazine Special Presentation
Half of American Private Firms Plan to Do Business Overseas Within Next 1 to 2 Years
PricewaterhouseCoopers
U.S. Falls to Fifth Place in New Report Identifying the World's Most Competitive Economies
Klaus Schwab, World Economic Forum
Grubb & Ellis: U.S. Logistics Market Experienced a Strong First Half of 2011
Grubb & Ellis
All Studies/Research/Papers